Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, OCREVUS, in reduc ...

The Cleveland Browns brought in what could turn out to be an all-time great 2025 NFL draft class, as a number of players on ...

Applications are invited for recruitment of various teaching and non-teaching posts or career in KV ONGC Nazira Assam in 2026. Kendriya Vidyal ...

U.S. Army Soldiers assigned to Bravo Company, 2-501st General Support Aviation Battalion, 1st Armored Division, Combat Aviation Brigade, execute tables III-VI during an aerial gunnery exercise at Novo ...

What happened on Days of our Lives, February 2nd through 6th, 2026, when Julie fought JJ, Rafe learned about Stefan’s kidnapping, Liam gave the police a sketch of Vivian’s henchman, Kristen fought Bra ...

Designed to reinforce lucerastat as the first oral therapy suitable for all patients with Fabry disease, irrespective of their mutation type. The program is expected to support a potential regulatory ...

GSK (GSK) results were the first for new chief executive and company veteran Luke Miels, who outlined a strategy to move the company’s sales towards higher-margin specialist medicines, based on a more ...

AUSTIN (KXAN) — The Round Rock Police Department said Wednesday that it arrested a behavior technician Monday after an alleged sexual assault of a minor at a residence in the city. RRPD said the minor ...

Sugar production in Uttar Pradesh declines due to lower crushing and yield, primarily affected by April-May rains.

MINNEAPOLIS - Bio-Techne Corporation (NASDAQ:TECH) reported flat revenue but improved profitability in its second quarter fiscal 2026 results, with adjusted earnings per share rising to $0.46 compared ...

The appellate tribunal quashed orders permitting bankruptcy against personal guarantors after a creditor consented to grant additional time to submit repayment plans under the insolvency ...

An international team confirms in a pioneering phase 3 clinical trial the decisive role of the time of day on the success of anti-tumour immunotherapies. Huang, Z., Zeng, L., Ruan, Z. et al.